| Malignant neoplasms in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors, tocilizumab, abatacept, or rituximab in clinical practice: a nationwide … H Wadström, T Frisell, J Askling, ... JAMA internal medicine 177 (11), 1605-1612, 2017 | 152* | 2017 |
| Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from Sweden H Wadström, T Frisell, P Sparén, J Askling Annals of the rheumatic diseases 75 (7), 1272-1278, 2016 | 84 | 2016 |
| Cervical neoplasia in systemic lupus erythematosus: a nationwide study H Wadström, EV Arkema, C Sjöwall, J Askling, JF Simard Rheumatology 56 (4), 613-619, 2017 | 63 | 2017 |
| How good is the coverage and how accurate are exposure data in the Swedish Biologics Register (ARTIS)? H Wadström, JK Eriksson, M Neovius, J Askling, ARTIS* Study Group Scandinavian journal of rheumatology 44 (1), 22-28, 2015 | 56 | 2015 |
| Short-and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice V Huss, H Bower, H Wadström, T Frisell, J Askling Rheumatology, 2021 | 38 | 2021 |
| Risk of breast cancer before and after rheumatoid arthritis, and the impact of hormonal factors H Wadström, A Pettersson, KE Smedby, J Askling Annals of the rheumatic diseases 79 (5), 581-586, 2020 | 32 | 2020 |
| Clinical Epidemiological Studies of the Association Between Chronic Inflammation, Immune-Modulatory Therapies, and Cancer H Wadström PQDT-Global, 2020 | | 2020 |
Thomas FrisellDocent, Principal Researcher, Clinical Epidemiology Division, Karolinska InstitutetVerifierad e-postadress på ki.se
